Tesomet: Ph IIa data

Top-line data from a double-blind, German Phase IIa trial in 60 Type II diabetics showed that 0.5 mg/100 mg oral Tesomet tesofensine/metoprolol met the primary endpoint of reducing mean 24-hour heart ...